BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Bargains & Bubbles

Netflix Is Earning More Than Ever. The Stock Is Down 37%. Both Things Are True.

Moe Alsumidaie by Moe Alsumidaie
September 11, 2026
in Bargains & Bubbles
0
74
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

The gist of it

The filed numbers show a business that has nearly doubled its profit margin in four years and is on track to generate more free cash flow this year than most S&P 500 companies earn in total revenue. The stock, meanwhile, is sitting 37% below its peak and trading at a lower earnings multiple than it has in three-quarters of the past decade. The math says the business is stronger than it has ever been. The mood, meaning what the market is currently willing to pay per dollar of profit, says the best days are behind it. Those two readings cannot both be right, and that disagreement is the story.

A company that nearly broke, then didn’t

In April 2022, Netflix announced it had lost subscribers for the first time in a decade, and the stock fell 35% in a single day, as the Los Angeles Times reported. The narrative that followed was brutal: streaming was maturing, password sharing was cannibalizing revenue, and the ad-free subscription model had a ceiling. The company looked like a business that had grown as far as it could grow.

What happened next rewrote that story. Netflix launched an ad-supported tier in late 2022, then cracked down on password sharing starting in May 2023. The crackdown alone caused new U.S. sign-ups to more than double in the weeks after launch, according to IGN, and the company added nearly nine million paid subscribers in the following quarter. The business that looked like it was running out of road had found a new one.

That backstory matters because it explains the shape of today’s numbers, and why the current price is so hard to read.

BullScope TerminalYou just read Netflix’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →

What the filings actually show

The Q2 2026 10-Q, filed July 17, is where the tension lives. Revenue for the quarter came in at $12.56 billion, up 13% from a year earlier. The operating margin, meaning what’s left of each dollar of sales after paying every bill to keep the lights on, hit 33.4%. To put that in human terms: for every dollar a subscriber pays, Netflix keeps about 33 cents as operating profit. Four years ago that figure was closer to 18 cents.

The full-year picture is just as striking. The 10-K for fiscal year 2025 shows revenue of $45.2 billion and a net margin of 24.3%, up from 16% just two years earlier. A business that expands its margin by that many percentage points while also growing its top line by more than a third is doing something genuinely unusual. Most companies get bigger or more profitable; Netflix has been doing both at the same time.

Management has narrowed its full-year 2026 revenue outlook to a tight band around $51 billion and is targeting an operating margin above 31% for the year, as TradingView reported. Free cash flow for the full year is guided at roughly $12.5 billion. That is a number worth anchoring: cash generated from operations at that scale exceeds the entire annual revenue of most companies in the S&P 500.

Where the mood diverges from the math

The stock closed around $80 on August 19, 2026, per our data, which is 37% below its June 2025 peak. The S&P 500, for context, gained more than a fifth over the same trailing year, according to CompaniesMarketCap data. A business posting record margins is being priced as if it is in decline.

The multiple, meaning the price tag the market puts on each dollar of profit, tells the same story. Our data shows Netflix trading at a price-to-earnings ratio of about 29.5 times, well below the company’s own decade-long median of 41.7 times. Today’s price sits in the bottom quarter of Netflix’s own historical valuation range. The market is paying less for each dollar of Netflix profit than it has in roughly three-quarters of the past ten years, even as those profits have never been larger.

BullScope TerminalNetflix was the article. The engine is the product.Same yardsticks, any ticker: filed financials in, math-vs-mood out. Nothing here is advice; it is the evidence, organized.Run another company →

The mood has a reason, though. The Q2 2026 earnings release on July 16 showed that forward revenue guidance came in at the lower end of prior expectations, and the stock had already fallen sharply from its peak. When a company guides for slower growth, the market tends to ask whether the deceleration is temporary or structural. That question is genuinely open, and the data cannot fully answer it.

The ad business and the content bet

The scene that matters most right now is not on a screen. It is in the advertising market. Netflix’s ad-supported tier has grown to more than 250 million monthly active users globally, up from a fraction of that in 2024, and management is targeting several billion dollars in ad revenue for 2026, according to TradingKey. That is a business that barely existed three years ago.

The cost of building it is real. Netflix plans to spend roughly $20 billion on content in 2026, about 10% more than it spent in 2025, as Forbes noted. That is a bet placed on the idea that more and better content keeps subscribers from leaving. The monthly churn rate, meaning the share of subscribers who cancel in a given month, held at about 2% through May 2026, which is low enough to suggest the content is working. Whether that level of annual spending is the right price to keep it working is a question the filings cannot answer.

Meanwhile, Netflix repurchased a single-quarter record amount of its own stock in Q2 2026 alone, and has tens of billions in remaining buyback authorization. That is management betting heavily that the stock is cheap.

What the conversation is saying

The analyst community is split in a way that mirrors the math-versus-mood tension almost perfectly. Goldman Sachs downgraded Netflix to a negative outlook rating on July 20, 2026. Barclays assigned an equal-weight rating with an analyst valuation estimate of $80 on July 17. On the other side, UBS maintained a buy with a $115 analyst estimate, and Morgan Stanley held its overweight rating, per MarketBeat’s consensus tracker. Bill Ackman’s Pershing Square disclosed a new position of more than three million shares on August 13, 2026, according to 247 Wall St., which noted that Ackman lost money on Netflix the last time he tried this. Morningstar’s Matthew Dolgin, writing on July 13, 2026, put fair value at $80, arguing the company is great but possibly priced for a maturity it has not yet earned.

BullScope TerminalWant the full evidence sheet behind pieces like this?The terminal runs the complete workup: Netflix and 500+ other names, on the same official data.See the evidence engine →

The honest summary: the people who think the stock is cheap are pointing at the margin trajectory and the ad business. The people who think it is fairly priced or worse are pointing at the growth deceleration. Both sides are reading the same filings.

Reading the numbers

  • Operating margin, 33.4% in Q2 2026 (Q2 2026 10-Q): the share of each dollar of revenue left after paying every operating cost. A household analogy: if a family earns $3,000 a month and has $2,000 in fixed bills, their operating margin is 33%. Netflix’s was closer to 18% in 2021, meaning the business now keeps nearly twice as much from each dollar it collects.
  • Net margin, 24.3% in FY2025 (10-K FY2025): what remains after taxes and interest, not just operating costs. Four years ago this was 17.2%. The direction of travel is unambiguous.
  • P/E ratio, 29.5 times, versus decade median of 41.7 times (our data): the price-to-earnings ratio is the price tag per dollar of annual profit. A P/E of 30 means the market pays $30 for every $1 the company earns. Netflix’s own ten-year median is $41.70 for that same dollar. Today’s price is a meaningful discount to the company’s own history, sitting in the bottom quarter of its decade range.
  • Free cash flow guidance, roughly $12.5 billion for full-year 2026 (TradingKey, citing Q2 2026 earnings): cash actually generated from running the business, after capital spending, before financing. A household equivalent: it is the money left in the checking account after all bills are paid and the car is maintained, before any loan payments. $12.5 billion in a single year is more than Netflix’s entire annual revenue was as recently as 2019.
  • Monthly churn rate, roughly 2% as of May 2026 (TradingKey): the share of subscribers who cancel in a given month. At 2%, a subscriber base of 325 million loses about 6.5 million members a month and must replace them just to stay flat. Holding that rate steady for twelve months while growing the base suggests the content spending is doing its job.

The open question the data cannot resolve is whether 13% revenue growth is a new normal or a floor. If it is a floor, the current multiple looks like a discount to history for a reason that no longer applies. If growth continues to slow toward the economy’s pace, the compression may be exactly right. That is the bet the market is making, and the filed numbers do not yet decide it.

For the standing yardsticks on Dow: the price tag, the filed record, and the four gauges, refreshed with each edition, see the BullScope Evidence Sheet: Dow.

For the standing yardsticks on Netflix: the price tag, the filed record, and the four gauges, refreshed with each edition, see the BullScope Evidence Sheet: Netflix.

Sources

  • Netflix 10-Q, quarter ended June 30, 2026 (SEC EDGAR)
  • Netflix 10-K, fiscal year ended December 31, 2025 (SEC EDGAR)
  • TradingKey: Netflix Q2 2026 earnings analysis
  • TradingView: Netflix Q2 2026 revenue and margin report
  • MarketBeat: Netflix analyst ratings and valuation estimates
  • CompaniesMarketCap: Netflix P/E ratio history
  • 247 Wall St.: Bill Ackman’s Pershing Square Netflix position
  • Los Angeles Times: Netflix stock plunge, April 2022
  • IGN: Netflix password-sharing crackdown and subscriber impact
  • Forbes: Netflix buyback versus content budget, April 2026
BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.
BullScope TerminalYou just read Netflix’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie

Moe Alsumidaie

Moe Alsumidaie, MBA, MSF, is founder and Chief Editor of Vanguard Publications, which publishes Clinical Trial Vanguard, Pharma Vanguard and BullScope, and Head of Research at CliniBiz. He has two decades in clinical trial operations and data science, with earlier roles at Genentech, Abbott Vascular and Stanford University Medical Center, and is a guest lecturer in clinical trial sciences at Rutgers University.

Recommended For You

Abbott’s Split Personality: Revenue Climbs 14%, the Stock Falls Anyway

by Moe Alsumidaie
October 22, 2026
0

Abbott Laboratories spent most of the pandemic era as a Wall Street darling, its COVID test sales turning a steady healthcare conglomerate into a growth story. Then the...

Read moreDetails

The $14 Acquisition Price and the Arbitrage Gap the Market Is Pricing

by Moe Alsumidaie
October 16, 2026
0

The short version Sun Pharmaceutical agreed in April 2026 to buy Organon for $14.00 a share in cash, a deal Organon shareholders approved in July. The stock trades...

Read moreDetails

From $8 to $0.45: Ascend Wellness Is Generating Real Cash While the Market Prices It for Failure

by Moe Alsumidaie
October 14, 2026
0

The story, briefly The math, meaning what the filed numbers actually show, tells a story of a cannabis retailer that turned cash-flow positive in 2023 and has been...

Read moreDetails

ADMA Biologics: A Business Earning Real Money, Priced Like It Might Not

by Moe Alsumidaie
October 13, 2026
0

Six years ago, ADMA Biologics was losing nearly two dollars for every dollar it brought in. The company made a single class of medicine, plasma-derived immunoglobulins (proteins collected...

Read moreDetails

Viatris: The Stock Has Run 72% in a Year. The Filed Numbers Tell a More Complicated Story.

by Moe Alsumidaie
October 9, 2026
0

The share price is up 72% over the past twelve months. Revenue has fallen every single year since 2021. Those two facts belong to the same company, and...

Read moreDetails
Next Post

Abbott's Split Screen: One Business Surging, One Shrinking, and a Stock Priced Somewhere in Between

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

AbbVie’s October Surprise: A $216 Million Charge and a Pipeline That Keeps Growing Anyway

October 13, 2026

Walmart’s Math Says One Thing. The Price Tag Says Another.

August 3, 2026

Evidence Sheet: Merck & Co (MRK)

September 7, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.